{
    "title": "Bayer flags new blood thinner as $5 bln-plus opportunity",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11618893/Bayer-flags-new-blood-thinner-5-bln-plus-opportunity.html",
    "date": "2023-01-10",
    "keywords": [
        "drug",
        "bayer",
        "blood",
        "revenue",
        "approval",
        "thinner",
        "share",
        "price",
        "activist",
        "burger",
        "patricia",
        "tuesday",
        "company",
        "outlook",
        "fund",
        "kerendia",
        "class",
        "factor",
        "johnson",
        "trial",
        "frankfurt",
        "jan",
        "interest",
        "thrombosis",
        "confidence",
        "protection",
        "courtroom",
        "group",
        "litigation",
        "weedkiller",
        "roundup",
        "pollution",
        "pcbs",
        "monsanto",
        "underperformance",
        "month",
        "investment",
        "capital",
        "hedge",
        "veteran",
        "jeffrey",
        "elliott",
        "stake",
        "profile",
        "nextgeneration",
        "potential",
        "year",
        "uptake",
        "growth",
        "china",
        "brighter",
        "picture",
        "stefan",
        "safety",
        "midstage",
        "latestage",
        "evidence",
        "efficacy",
        "xi",
        "novartis",
        "partner",
        "equity",
        "firm",
        "blackstone",
        "close",
        "contestant",
        "race",
        "squibb",
        "candidate",
        "milvexian",
        "oelrich",
        "programme",
        "request",
        "progress",
        "phase",
        "chance",
        "stage",
        "goal",
        "market",
        "stroke",
        "prevention",
        "fibrillation",
        "form",
        "heartbeat",
        "opportunity",
        "weiss",
        "editing",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}